Goldberg John Mayer 4
4 · Oncorus, Inc. · Filed Mar 2, 2022
Insider Transaction Report
Form 4
Oncorus, Inc.ONCR
Goldberg John Mayer
SVP, Clinical Development
Transactions
- Award
Employee Stock Option (right to buy)
2022-03-01+84,500→ 84,500 totalExercise: $2.00Exp: 2032-02-29→ Common Stock (84,500 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service through each such vesting date.